Tumour necrosis factor alpha kinoid

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTumour necrosis factor alpha kinoid
Drug Alias Name肿瘤坏死因子-α kinoidTNFα-kinoidTNF-alpha kinoidTNF-K005TNF-K
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsCrohn DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[19] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeovacs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeovacs
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A